Singapore Pathology
June 2024

ICCR welcomes Singapore Pathology as a new sustaining member of the ICCR. Professor Puay Hoon Tan will be the representative on the Dataset Steering Committee.

Singapore Pathology is a histopathologist led entity that aims to provide evidence based, accurate, reliable and timely interpretations for breast and urologic pathology, in partnership with existing laboratory establishments.

The scope encompasses second opinion consultation, direct reporting of surgical and cytology specimens including adjunctive immunohistochemistry, as well as intraoperative frozen section evaluation.

Singapore Pathology is committed to international collaborations that promote best practices in pathology diagnostics and tumour classification for optimal patient care.

The contribution of the Singapore Pathology is warmly welcomed.

By using this website, you acknowledge that you have read and understand the Privacy Policy. It appears you're using an old version of Internet Explorer for safer and optimum browsing experience please upgrade your browser.